Tamoxifen Terminated Phase 3 Trials for Stage IV Breast Cancer / Stage IIIB Breast Cancer / Stage IIIA Breast Cancer / Inflammatory carcinoma of the breast / Cardiac Toxicity Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00016276Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer